Clinical Trials Browser

Completed × Observational × Erlotinib Hydrochloride × Clear all

Carcinoma, Non-Small-Cell Lung

NCT02154490 2023-06-01

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Completed

1,864 enrolled 12 charts

Recurrent Squamous Cell Lung Carcinoma

NCT04179890 2023-05-25

UpSwinG

Completed

462 enrolled 23 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Completed

338 enrolled 18 charts

Gastrointestinal

Pancreatic Neoplasms

NCT01836133 2017-05-04

ELEMENT

Completed

70 enrolled 8 charts

Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT01161173 2016-03-28

TEAM

Completed

347 enrolled 10 charts

Nonsquamous Nonsmall Cell Neoplasm of Lung

NCT01664533 2015-12-28

TIME

Completed

57 enrolled 10 charts

Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT00418704 2013-10-01

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT00419042 2013-10-01

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

Completed

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Clinical Trials

DELINOR

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

UpSwinG

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

ELEMENT

TEAM

TIME

Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)